Janssen Infectious Diseases BVBA, Turnhoutseweg 30, 2340 Beerse, Belgium.
J Virol Methods. 2013 Feb;187(2):238-47. doi: 10.1016/j.jviromet.2012.11.016. Epub 2012 Nov 23.
Early HIV-1 integrase inhibitors, such as compounds containing a β-diketo acid moiety, were identified by extensive high-throughput screening campaigns. Traditionally, in vitro biochemical assays, measuring the catalytic activities of integrase, have been used for this purpose. However, these assays are confounded by the absence of cellular processes or cofactors that play a role in the integration of HIV-1 DNA in the cellular genome. In contrast to regular cell-based virus inhibition assays, which targets all steps of the viral replication cycle, a novel cellular screening assays was developed to enable the specific identification of integrase inhibitors, employing a readout that is linked with the inhibition of integrase activity. Therefore, a HIV-1 lentiviral vector equipped with the enhanced green fluorescent protein (eGFP) reporter gene was used to detect expression from extrachromosomal viral DNA (1- or 2-long terminal repeat circles), formed when integration of vector DNA into the cellular genome is prevented by an integrase inhibitor. In this assay, eGFP expression from the low residual level of transcriptional activity of extrachromosomal DNA was measured via high-throughput flow cytometry. An algorithm for analysis of eGFP expression histograms enabled the specific identification of integrase inhibitors. This assay is amenable for high throughput screening to identify inhibitors of HIV-1 integrase.
早期的 HIV-1 整合酶抑制剂,如含有β-二酮酸部分的化合物,是通过广泛的高通量筛选活动发现的。传统上,用于此目的的是体外生化测定法,该测定法测量整合酶的催化活性。然而,这些测定法受到细胞过程或辅助因子的缺失的干扰,这些过程或辅助因子在 HIV-1 DNA 整合到细胞基因组中起着作用。与针对病毒复制周期所有步骤的常规基于细胞的病毒抑制测定法相反,开发了一种新型的细胞筛选测定法,以能够特异性鉴定整合酶抑制剂,该测定法采用与抑制整合酶活性相关的读出值。因此,使用带有增强型绿色荧光蛋白(eGFP)报告基因的 HIV-1 慢病毒载体来检测由于整合酶抑制剂而阻止载体 DNA 整合到细胞基因组中时形成的染色体外病毒 DNA(1 个或 2 个长末端重复环)的表达。在该测定法中,通过高通量流式细胞术测量来自染色体外 DNA 的低转录活性的 eGFP 表达。用于分析 eGFP 表达直方图的算法可用于特异性鉴定整合酶抑制剂。该测定法适用于高通量筛选,以鉴定 HIV-1 整合酶抑制剂。